Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > On GLP-1 agonists US Senate passes anti-patent thicket bill

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jul 18, 2024 9:41am

70 Views

Post# 36138138

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:On GLP-1 agonists US Senate passes anti-patent thicket bill

What a shame that you and so many others are so brainwashed that you totally ignore the 20% inflation, the two completely avoidable wars going on right now because of Biden's failures, the disgusting ongoing criminal border crisis that has allowed over ten million illegals to simply walk in to this country, many of whom have been sexually assaulting and murdering innocent Americans, and all your little brainwashed brain can manage to focus on is "Oh, he's his boy alright"....very sad!

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting